Treatment of cryptococcal meningitis in Peruvian AIDS Patients using amphotericin B and fluconazole

Journal of Infection

Volumn 57, Issue 3, 2008, Pages 260-265

  Dammert, P ^a   Bustamante, B ^b,c,d   Ticona, E ^e   Llanos Cuentas, A ^b,c,f   Huaroto, L ^e   Chavez V M ^e   Campos, P E ^d,f  

^a Jr Hospital of Cook County   (United States)

^b INSTITUTO DE MEDICINA TROPICAL ALEXANDER VON HUMBOLDT   (Peru)

^c HOSPITAL NACIONAL CAYETANO HEREDIA   (Peru)

^d Investigaciones Médicas en Salud ^*  (Peru)

^e HOSPITAL NACIONAL DOS DE MAYO   (Peru)

^f UNIVERSIDAD PERUANA CAYETANO HEREDIA   (Peru)

Author keywords

AIDS; Amph B deoxycholate (Amph B); Cryptococcal meningitis (CM); Fluconazole

Indexed keywords

ALBUMIN; AMPHOTERICIN B DEOXYCHOLATE; ANTIRETROVIRUS AGENT; FLUCONAZOLE; FUNGUS ANTIGEN; LAMIVUDINE; SODIUM; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AIDS PATIENT; AIDS RELATED COMPLEX; ALLERGIC RASH; ANEMIA; ANTIGEN DETECTION; ARTICLE; BLOOD CULTURE; BODY MASS; CEREBROSPINAL FLUID ANALYSIS; CEREBROSPINAL FLUID CULTURE; CEREBROSPINAL FLUID PRESSURE; CLINICAL ARTICLE; CLINICAL TRIAL; CREATININE BLOOD LEVEL; CRYPTOCOCCAL MENINGITIS; CRYPTOCOCCUS NEOFORMANS; DISEASE ASSOCIATION; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG RESPONSE; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; GASTROINTESTINAL HEMORRHAGE; HUMAN; HYPOALBUMINEMIA; HYPOKALEMIA; HYPONATREMIA; INTRACRANIAL HYPERTENSION; LOADING DRUG DOSE; MALE; MORTALITY; MULTIVARIATE ANALYSIS; PERU; PNEUMONIA; SEIZURE; SIDE EFFECT; THROMBOCYTOPENIA; UNIVARIATE ANALYSIS; URINE CULTURE; VOMITING;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; AMPHOTERICIN B; ANTIFUNGAL AGENTS; BLOOD; CEREBROSPINAL FLUID; CRYPTOCOCCUS; FEMALE; FLUCONAZOLE; HUMANS; INTRACRANIAL PRESSURE; MALE; MENINGITIS, CRYPTOCOCCAL; PERU; RISK FACTORS; TREATMENT OUTCOME; URINE;

EID: 50449086000     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jinf.2008.06.020     Document Type: Article

References (30)

1. Powderly W.G. Cryptococcal meningitis and AIDS. Clin Infect Dis 17 (1993) 837-842
2. Chuck S.L., and Sande M.A. Infections with cryptococcus in the acquired immunodeficiency syndrome. N Engl J Med 321 12 (1989) 794-799
3. Zuger A., Louis E., Holzman R.S., Simberkoff M.S., and Rahal J.J. Cryptococcal disease in patients with the acquired immunodeficiency syndrome: diagnostic features and outcome of treatment. Ann Intern Med 104 2 (1986) 234-240
4. Currie B.P., and Casadevall A. Estimation of the prevalence of cryptococcal infection among patients infected with the human immunodeficiency virus in New York City. Clin Infect Dis 19 2 (1994) 1029-1033
5. Cahn P., Belloso W., Murillo J., and Prada-Trujillo G. AIDS in Latin America. Infect Dis Clin North Am 14 1 (2000) 185-209
6. Pappalardo M.C., and Melhem M.S. Cryptococcosis: a review of the Brazilian experience for the disease. Rev Inst Med Trop Sao Paulo 45 6 (2003) 299-305
7. Clumeck N., Carael N., and Van de Perre P. The African AIDS experience in contrast with the rest of the world. In: Leong G., and Mills J. (Eds). Opportunistic infections in patients with the acquired immunodeficiency syndrome (1989), Marcel Decker, New York 43-56
8. Campos P., and Rojas R. Complicaciones infecciosas del sistema nervioso central en el SIDA. In: Sanchez J., Mazzoti G., Cuellar L., Campos P., and Gotuzzo E. (Eds). SIDA, epidemiología, diagnóstico, tratamiento y control de la infección VIH SIDA (1994), OMS/OPS MINSA, Perú 141-149
9. Mirza S.A., Phelan M., Rimland D., Gravis E., Hamill R., Brandt M.E., et al. The changing epidemiology of cryptococcosis: an update from population-based active surveillance in 2 large metropolitan areas, 1992-2000. Clin Infect Dis 36 6 (2003) 789-794
10. Manzardo C., Del Mar Ortega M., Sued O., Garcia F., Moreno A., and Miro J.M. Central nervous system opportunistic infections in developed countries in the highly active antiretroviral therapy era. J Neurovirol 11 Suppl. 3 (2005) 72-82
11. Dromer F., Mathoulin-Pelissier S., Fontanet A., Ronin O., Dupont B., and Lortholary O. Epidemiology of HIV-associated cryptococcosis in France (1985-2001): comparison of the pre- and post-HAART eras. AIDS 18 3 (2004) 555-562
12. Casadevall A., and Perfect J. Therapy of cryptococcosis. In: Casadevall A., and Perfect J. (Eds). Cryptococcus neoformans (1998), American Society for Microbiology Press 457-518
13. Van Der Horst C., Saag M., Cloud G., Hamill R.J., Graybill J.R., Sobel J.D., et al. Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. N Engl J Med 337 1 (1997) 15-21
14. Pitisuttithum P., Tansuphasawadikul A., Simpson A.J.H., Howe P.A., and White N.J. A prospective study of AIDS-associated Cryptococcal Meningitis in Thailand treated with high-dose Amph B. J Infect 43 4 (2001) 226-233
15. Robinson P.A., Bauer M., Leal M.A., Evans S.G., Holtom P.D., Diamond D.A., et al. Early mycological treatment failure in AIDS-associated cryptococcal meningitis. Clin Infect Dis 28 1 (1999) 82-92
16. Brouwer A.E., Rajanuwong A., Chierakul W., Griffin G.E., Larsen R.A., White N.J., et al. Combination antifungal therapies for HIV-associated cryptococcal meningitis: a randomized trial. Lancet 363 9423 (2004) 1764-1767
17. Darras-Joly C., Chevret S., Wolf M., Matheron S., Longuet P., Casalino E., et al. Cryptococcus neoformans infection in France: epidemiologic features of and early prognostic parameters for 76 patients who were infected with the human immunodeficiency virus. Clin Infect Dis 23 2 (1996) 369-376
18. Dromer F., Mathoulin-Pelissier S., Launay O., Lortholary O., and the French Cryptococcosis Study Group. Determinants of disease presentation and outcome during Cryptococcosis: the CryptoA/D study. PLoS Med 4 2 (2007) E21
19. Witt M.D., Lewis R.J., Larsen R.A., Milefchik E.N., Leal M.A., Haubrich R.H., et al. Identification of patients with acute AIDS associated cryptococcal meningitis who can be effectively treated with fluconazole: the role of antifungal susceptibility testing. Clin Infect Dis 22 2 (1996) 322-328
20. Heyderman R.S., Gangaidzo I.T., Hakim J.G., Mielke J., Taziwa A., Musvaire P., et al. Cryptococcal meningitis in human immunodeficiency virus-infected patients in Harare, Zimbabwe. Clin Infect Dis 26 2 (1998) 284-289
21. Pappas P.G., Bustamante B., Ticona E., Hamill R.J., Johnson P.C., Reboli A., et al. Recombinant interferon-gamma 1b as adjunctive therapy for AIDS-related acute cryptococcal meningitis. J Infect Dis 189 12 (2004) 2185-2191
22. Monaco L.S., Silva Nieto F., Warley E., and Cervelli M.R. Criptococosis meníngea asociada al SIDA en el Hospital Diego Paroissien en el periodo 1996/1999. Rev Argent Microbiol 33 2 (2001) 118-121
23. Darze C., Lucena R., Gomes I., and Melo A. Clinical and laboratory characteristics of 104 cryptococcus meningoencephalitis cases. Rev Soc Bras Med Trop 33 1 (2000) 21-26
24. Llanos-Cuentas A, Ticona E, Bustamante B, Chávez V, Bazán L, De La Grecca R, et al, Nyotran: a new alternative treatment for cryptococcal meningitis. In: XVth International Congress for Tropical Medicine and Malaria. Abstract books, vol. 2. Cartagena de Indias, Santa Fe de Bogotá, Colombia: Corcas Editores; August 20-25, 2000. p. 46.
25. Wanke C.A., Silva M., Knox T.A., Forrester J., Speigelman D., and Gorbach S.L. Weight loss and wasting remain common complications in individuals infected with human immunodeficiency virus in the era of highly active antiretroviral therapy. Clin Infect Dis 31 (2000) 803-804
26. Jones J.L., Hanson D.L., Dworkin M.S., Alderton D.L., Fleming P.L., Kaplan J.E., et al. Surveillance for AIDS-defining opportunistic illnesses, 1992-1997. MMWR CDC Surveill Summ 48 (1999) 1-22
27. Chlebowski R.T., Grosvenor M.B., Bernhard N.H., Morales L.S., and Bulcavage L.M. Nutritional status, gastrointestinal dysfunction, and survival in patients with AIDS. Am J Gastroenterol 84 10 (1989) 1288-1293
28. Palenicek J.P., Graham N.M., He Y.D., Hoover D.A., Oishi J.S., Kingsley L., et al. Weight loss prior to clinical AIDS as a predictor of survival. Multicenter AIDS cohort study investigators. J Acquir Immune Defic Syndr Hum Retrovirol 10 3 (1995) 366-373
29. Wheeler D.A., Gibert C.L., Launer C.A., Muurahainen N., Elion R.A., Abrams D.I., et al. Weight loss as a predictor of survival and disease progression in HIV infection. Terry Beirn Community Programs for Clinical Research on AIDS. J Acquir Immune Defic Syndr Hum Retrovirol 18 1 (1998) 80-85
30. Graybill J.R., Sobel J., Saag M., van Der Horst C., Powderly W., Cloud G., et al. Diagnosis and management of increased intracranial pressure in patients with aids and cryptococcal meningitis. The NIAID Mycoses Study Group and AIDS Cooperative Treatment Groups. Clin Infect Dis 30 1 (2000) 47-54